BTOG 2019 | The Manchester Lung Health Check Pilot: integrating biomarkers into screening
Philip Crosbie
The Manchester Lung Health Check Pilot has taken screening into the community, where many are at high-risk of lung cancer, as discussed here by Philip Crosbie, MBChB, MRCP, PhD, of the University of Manchester, Manchester, UK. Speaking from the British Thoracic Oncology Group (BTOG) 2019 Annual Conference in Dublin, Ireland, Dr Crosbie highlights how blood samples in the second round were used for biomarker screening, which has provided a model for patient selection for screening.
Related videos
2:03
TKIs to treat EGFRm-positive NSCLC
Marina Garassino
1:16
The promise of stereotactic radiotherapy for oligometastases
Françoise Mornex
1:50
Prof. Kelly’s overview of the RECaN project
Daniel Kelly
1:03
Managing oligometastatic NSCLC with thoracic irradiation
Françoise Mornex
2:06
Afatinib for advanced EGFRm-positive NSCLC
Antonio Passaro
